Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02DLE
|
||||
Former ID |
DNC003542
|
||||
Drug Name |
CGS-26303
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Terminated | [546022] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H18N5O3P
|
||||
Canonical SMILES |
C1=CC=C(C=C1)C2=CC=C(C=C2)CC(C3=NNN=N3)NCP(=O)(O)O
|
||||
InChI |
1S/C16H18N5O3P/c22-25(23,24)11-17-15(16-18-20-21-19-16)10-12-6-8-14(9-7-12)13-4-2-1-3-5-13/h1-9,15,17H,10-11H2,(H2,22,23,24)(H,18,19,20,21)/t15-/m0/s1
|
||||
InChIKey |
UUMKQZVEZSXWBY-HNNXBMFYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Neutral endopeptidase | Target Info | Inhibitor | [551340] | |
NetPath Pathway | EGFR1 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.